Mood Disorders Associated With Pituitary Adenoma: Review of Literature

Authors

Keywords:

pituitary adenoma, Mood disorders, Depression, anxiety, ACTH, Prolactinoma, apathy, TSH, neuropsychiatry

Abstract


Pituitary adenomas are linked to various mood disorders, including depression, mania, and anxiety disorders. Additionally, these adenomas have been observed to present other psychiatric symptoms, such as eating disorders and suicidal ideation. A thorough literature review was conducted, utilizing diverse search engines, including PubMed, Cochrane, and Google Scholar. The search terms used included "pituitary adenomas," "mood disorders," "Hypothalamo-pituitary axis," "hypopituitarism," "acromegaly," "depression," "mania," and "psychosis." The selected publications comprised case reports and pertinent research articles. There is a high prevalence of comorbidity between pituitary adenomas and depressive and anxiety disorders. The manifestation of these symptoms can be attributed to the endocrine dysfunction associated with pituitary adenomas, as well as the physical impact and tumor growth. Furthermore, it has been noted that apathy syndrome and chronic fatigue syndrome may be misdiagnosed as depression among individuals in this specific patient demographic. The presence of mood disorders can influence the process of diagnosing and treating pituitary adenomas. Diseases of this nature can potentially affect patients' daily functioning and their ability to engage in social activities. These individuals require appropriate medical intervention to improve their prognosis.

Author Biography

Dr. M A Magoha, Department of Surgery, University of Nairobi

Neurological Surgeon, Lecturer Department of Surgery (University Of Nairobi)

References

Harrison PJ. The neuropathology of primary mood disorder. Brain. 2002 Jul 1;125(7):1428–49.

Madhusoodanan S, Danan D, Moise D. Psychiatric manifestations of brain tumors: diagnostic implications. Expert Rev Neurother. 2007 Apr;7(4):343–9.

Brain tumor location and psychiatric symptoms: is there any association? A meta-analysis of published case studies: Expert Review of Neurotherapeutics: Vol 10, No 10 [Internet]. [cited 2022 Mar 3]. Available from: https://www.tandfonline.com/doi/abs/10.1586/ern.10.94

Bunevicius A, Deltuva VP, Deltuviene D, Tamasauskas A, Bunevicius R. Brain Lesions Manifesting as Psychiatric Disorders: Eight Cases. CNS Spectr. 2008 Nov;13(11):950–8.

Madhusoodanan S, Ting MB, Farah T, Ugur U. Psychiatric aspects of brain tumors: A review. World J Psychiatry. 2015 Sep 1;5(3):273–85.

Zada G, Woodmansee W, Kaiser U, Laws ER. Pituitary Adenomas. In: Norden AD, Reardon DA, Wen PCY, editors. Primary Central Nervous System Tumors: Pathogenesis and Therapy [Internet]. Totowa, NJ: Humana Press; 2011 [cited 2022 Mar 7]. p. 377–400. (Current Clinical Oncology). Available from: https://doi.org/10.1007/978-1-60761-166-0_16

Asa S, Ezzat S. The Cytogenesis and Pathogenesis of Pituitary Adenomas. Endocr Rev. 1999 Jan 1;19:798–827.

Madhusoodanan S, Ting MB, Wilson SY. Chapter 16 - The psychopharmacology of primary and metastatic brain tumors and paraneoplastic syndromes. In: Reus VI, Lindqvist D, editors. Handbook of Clinical Neurology [Internet]. Elsevier; 2019 [cited 2022 Mar 10]. p. 269–83. (Psychopharmacology of Neurologic Disease; vol. 165). Available from: https://www.sciencedirect.com/science/article/pii/B9780444640123000162

Cardoso F, Azizi H, Kilpatrick A, Olayinka O, Khan T, Kahn A, et al. Chronic Atypical Depression as an Early Feature of Pituitary Adenoma: A Case Report and Literature Review. Case Rep Psychiatry. 2019 Jul 21;2019:e4892183.

KRISHNAN KRR, DORAISWAMY PM, LURIE SN, FIGIEL GS, HUSAIN MM, BOYKO OB, et al. Pituitary Size in Depression*. J Clin Endocrinol Metab. 1991 Feb 1;72(2):256–9.

Sievers C, Ising M, Pfister H, Dimopoulou C, Schneider HJ, Roemmler J, et al. Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls. Eur J Endocrinol. 2009 Mar 1;160(3):367–73.

Hendrick V, Altshuler L, Whybrow P. PSYCHONEUROENDOCRINOLOGY OF MOOD DISORDERS: The Hypothalamic-Pituitary-Thyroid Axis. Psychiatr Clin North Am. 1998 Jun 1;21(2):277–92.

Weitzner MA, Kanfer S, Booth-Jones M. Apathy and Pituitary Disease: It Has Nothing to Do With Depression. J Neuropsychiatry Clin Neurosci. 2005 May;17(2):159–66.

Kelly WF, Kelly MJ, Faragher B. A prospective study of psychiatric and psychological aspects of Cushing’s syndrome. Clin Endocrinol (Oxf). 1996;45(6):715–20.

Bratek A, Koźmin -Burzyńsk, Górniak E, Krysta K. Psychiatric disorders associated with Cushing’s syndrome. Psychiatr Danub. 2015;27(1):339–43.

Sonino N, Fava GA. Psychiatric Disorders Associated with Cushing??s Syndrome: Epidemiology, Pathophysiology and Treatment. CNS Drugs. 2001;15(5):361–73.

Mattoo SK, Bhansali AK, Gupta N, Grover S, Malhotra R. Psychosocial morbidity in Cushing disease: a study from India. Endocrine. 2009 Jun 1;35(3):306–11.

Sharawat I, Panda P. Isolated neuropsychiatric features with non-functioning pituitary adenoma: Association or coincidence? J Pediatr Neurosci. 2021;16(4):315.

De Herdt C, Philipse E, De Block C. ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases. Eur J Endocrinol. 2021 Aug 1;185(2):R65–74.

Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B. Depression, Anxiety, Health-Related Quality of Life, and Disability in Patients with Overt and Subclinical Thyroid Dysfunction. Arch Med Res. 2006 Jan 1;37(1):133–9.

Anagnostis P, Efstathiadou ZA, Charizopoulou M, Selalmatzidou D, Karathanasi E, Poulasouchidou M, et al. Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases? Endocrine. 2014 Nov 1;47(2):564–71.

Pertichetti M, Serioli S, Belotti F, Mattavelli D, Schreiber A, Cappelli C, et al. Pituitary adenomas and neuropsychological status: a systematic literature review. Neurosurg Rev. 2020 Aug 1;43(4):1065–78.

Litofsky NS, Resnick AG. The relationships between depression and brain tumors. J Neurooncol. 2009 Sep 1;94(2):153–61.

Cohen LM, Greenberg DB, Murray GB. Neuropsychiatric presentation of men with pituitary tumors (the ‘four A’s’). Psychosomatics. 1984 Dec 1;25(12):925–8.

Ali S, Klahr Miller K, Freudenreich O. Management of Psychosis Associated With a Prolactinoma: Case Report and Review of the Literature. Psychosomatics. 2010 Sep 1;51(5):370–6.

Leo RJ, Burnett GJ, Hassett MJ. Psychosis associated with hypopituitarism. Gen Hosp Psychiatry. 1998 Jul 1;20(4):248–54.

Tooze A, Hiles CL, Sheehan JP. Neurocognitive Changes in Pituitary Adenoma Patients After Gamma Knife Radiosurgery: A Preliminary Study. World Neurosurg. 2012 Jul 1;78(1):122–8.

Satzer D, Bond DJ. Mania secondary to focal brain lesions: implications for understanding the functional neuroanatomy of bipolar disorder. Bipolar Disord. 2016;18(3):205–20.

Lisanby SH, Kohler C, Swanson CL, Gur RE. Psychosis Secondary to Brain Tumor. Semin Clin Neuropsychiatry. 1998 Jan 1;3(1):12–22.

Kate S, Dhanwal DK, Kumar S, Bharti P. Acute psychosis as a presentation of hypopituitarism. Case Rep. 2013 Jul 13;2013:bcr2012008516.

Arnold SD, Forman LM, Brigidi BD, Carter KE, Schweitzer HA, Quinn HE, et al. Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro-Oncol. 2008 Apr 1;10(2):171–81.

Uher R, Treasure J. Brain lesions and eating disorders. J Neurol Neurosurg Psychiatry. 2005 Jun 1;76(6):852–7.

Madhusoodanan S, Opler MG, Moise D, Gordon J, Danan DM, Sinha A, et al. Brain tumor location and psychiatric symptoms: is there any association? A meta-analysis of published case studies. Expert Rev Neurother. 2010 Oct 1;10(10):1529–36.

Dhungana S, Ojha SP, Chapagai M, Tulachan P. Pituitary Adenoma Presenting as Anorexia Nervosa: A Case Report. J Psychiatr Assoc Nepal. 2015;4(1):57–9.

Butler JM, Rapp SR, Shaw EG. Managing the cognitive effects of brain tumor radiation therapy. Curr Treat Options Oncol. 2006 Nov 1;7(6):517–23.

Athanasoulia A. Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas [Internet] [Theses (Dissertation, LMU Munich)]. LMU München; 2012 [cited 2022 Mar 3]. Available from: https://edoc.ub.uni-muenchen.de/14553/

Pérez-Esparza R, Rojas-Guerrero CA, Andino-Rios GG, Arias-Garro P, Ramírez-Bermúdez J, Portocarrero-Ortiz L. Clozapine Treatment for Cabergoline-Induced Psychosis in a Patient With a Giant Prolactinoma. J Neuropsychiatry Clin Neurosci. 2017 Jul;29(3):295–7.

Furgal-Borzych A, Lis GJ, Litwin JA, Rzepecka-Wozniak E, Trela F, Cichocki T. Increased Incidence of Pituitary Microadenomas in Suicide Victims. Neuropsychobiology. 2007;55(3–4):163–6.

Downloads

Published

30-01-2024

How to Cite

1.
Nageyle FM, Magoha MA. Mood Disorders Associated With Pituitary Adenoma: Review of Literature. EAJNS [Internet]. 2024 Jan. 30 [cited 2024 Jul. 25];3(1):27-3. Available from: https://theeajns.org/index.php/eajns/article/view/224

Issue

Section

Review articles